Testing the mutant selection window hypothesis with Escherichia coli exposed to levofloxacin in a rabbit tissue cage infection model
Authors:
- 14 September 2013
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 33 (3) , 385-389
Abstract
The purpose of this study was to test the mutant selection window (MSW) hypothesis with Escherichia coli exposed to levofloxacin in a rabbit model and to compare in vivo and in vitro exposure thresholds that restrict the selection of fluoroquinolone-resistant mutants. Local infection with E. coli was established in rabbits, and the infected animals were treated orally with various doses of levofloxacin once a day for five consecutive days. Changes in levofloxacin concentration and levofloxacin susceptibility were monitored at the site of infection. The MICs of E. coli increased when levofloxacin concentrations at the site of infection fluctuated between the lower and upper boundaries of the MSW, defined in vitro as the minimum inhibitory concentration (MIC99) and the mutant prevention concentration (MPC), respectively. The pharmacodynamic thresholds at which resistant mutants are not selected in vivo was estimated as AUC24/MPC > 20 h or AUC24/MIC > 60 h, where AUC24 is the area under the drug concentration time curve in a 24-h interval. Our finding demonstrated that the MSW existed in vivo. The AUC24/MPC ratio that prevented resistant mutants from being selected estimated in vivo is consistent with that observed in vitro, indicating it might be a reliable index for guiding the optimization of antimicrobial treatment regimens for suppression of the selection of antimicrobial resistance.Keywords
This publication has 26 references indexed in Scilit:
- Testing the mutant selection window in rabbits infected with methicillin-resistant Staphylococcus aureus exposed to vancomycinJournal of Antimicrobial Chemotherapy, 2012
- Evaluation of fluoroquinolone reduced dosage regimens in elderly patients by using pharmacokinetic modelling and Monte Carlo simulationsJournal of Antimicrobial Chemotherapy, 2012
- Temporal Interplay between Efflux Pumps and Target Mutations in Development of Antibiotic Resistance in Escherichia coliAntimicrobial Agents and Chemotherapy, 2012
- Mutant Prevention Concentration-Based Pharmacokinetic/Pharmacodynamic Indices as Dosing Targets for Suppressing the Enrichment of Levofloxacin-Resistant Subpopulations of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2011
- Effect of N-1/C-8 Ring Fusion and C-7 Ring Structure on Fluoroquinolone LethalityAntimicrobial Agents and Chemotherapy, 2010
- Modeling antibiotic resistance to project future rates: quinolone resistance in Escherichia coliEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- Mechanisms Accounting for Fluoroquinolone Resistance in Escherichia coli Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2009
- A unified anti-mutant dosing strategyJournal of Antimicrobial Chemotherapy, 2008
- Pharmacodynamic Assessment Based on Mutant Prevention Concentrations of Fluoroquinolones To Prevent the Emergence of Resistant Mutants of Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 2007
- Influence of Inoculum Size on the Selection of Resistant Mutants of Escherichia coli in Relation to Mutant Prevention Concentrations of MarbofloxacinAntimicrobial Agents and Chemotherapy, 2007